Free Trial

Adaptimmune Therapeutics (ADAP) Institutional Ownership

Adaptimmune Therapeutics logo
$0.60 +0.00 (+0.82%)
(As of 12/20/2024 05:51 PM ET)

Institutional Ownership Changes (13F Filings) for Adaptimmune Therapeutics (NASDAQ:ADAP)

Current
Institutional Ownership
Percentage
31.37%
Number of
Institutional Buyers
(last 12 months)
15
Total
Institutional Inflows
(last 12 months)
$4.15M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$4.19M
Get ADAP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Adaptimmune Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ADAP Institutional Buying and Selling by Quarter

Adaptimmune Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/20/2024 Virtu Financial LLC101,008$96K0.0%+27.5%0.039%
11/15/2024 Jane Street Group LLC174,157$166K0.0%+130.4%0.068%
11/15/2024 Matrix Capital Management Company LP37,681,515$35.81M1.7%-3.3%14.734%
11/14/2024 PFM Health Sciences LP10,000,787$9.51M0.5%-4.9%3.911%
11/13/2024 FMR LLC1,740,900$1.66M0.0%+3.0%0.681%
11/5/2024 Baillie Gifford & Co.16,775,860$15.94M0.0%+10.7%6.560%
11/5/2024 GSA Capital Partners LLP99,662$95K0.0%N/A0.039%
10/29/2024 Fullcircle Wealth LLC35,000$33K0.0%N/A0.014%
10/16/2024 Vontobel Holding Ltd.43,000$41K0.0%+230.8%0.017%
8/15/2024 Long Focus Capital Management LLC12,346,417$12.04M0.5%+15.6%5.002%
8/14/2024 Marshall Wace LLP144,880$141K0.0%-43.0%0.059%
8/9/2024 Renaissance Technologies LLC1,786,341$1.74M0.0%+28.3%0.724%
7/25/2024 Baillie Gifford & Co.15,149,203$14.77M0.0%-4.6%6.138%
5/15/2024 Baker BROS. Advisors LP10,787,022$17.04M0.2%-1.7%4.370%
5/14/2024 Boulder Hill Capital Management LP90,800$143K0.1%N/A0.037%
5/3/2024 GSA Capital Partners LLP370,179$585K0.0%-27.2%0.150%
5/1/2024 Baillie Gifford & Co.15,871,875$25.08M0.0%-0.3%6.431%
4/19/2024JTC Employer Solutions Trustee Ltd26,156$41K0.0%N/A0.003%
4/15/2024Key Client Fiduciary Advisors LLC268,655$424K0.2%-20.2%0.027%
4/15/2024Columbia Advisory Partners LLC15,585$25K0.0%N/A0.002%
3/5/2024 Twin Focus Capital Partners LLC55,526$44K0.0%N/A0.006%
1/26/2024 Baillie Gifford & Co.15,912,140$12.62M0.0%-7.2%1.600%
1/9/2024Key Client Fiduciary Advisors LLC336,620$267K0.2%+6.4%0.034%
1/8/2024 Harbor Capital Advisors Inc.147,732$117K0.0%+9.9%0.015%
11/13/2023 Baillie Gifford & Co.17,147,409$13.38M0.0%-0.2%1.725%
10/27/2023 Marquette Asset Management LLC99,349$77K0.0%N/A0.010%
10/27/2023 Acuitas Investments LLC479,764$374K0.2%N/A0.048%
10/20/2023 Harbor Capital Advisors Inc.134,415$105K0.0%+19.5%0.014%
9/21/2023 Barclays PLC50,061$46K0.0%N/A0.005%
9/7/2023 MPM Asset Management LLC6,287,101$5.82M2.9%N/A0.632%
8/15/2023 Black Maple Capital Management LP69,839$65K0.0%N/A0.007%
8/14/2023 X Square Capital LLC26,771$25K0.0%N/A0.003%
8/14/2023 CSS LLC IL90,702$84K0.0%N/A0.009%
8/11/2023 Artal Group S.A.1,133,775$1.05M0.0%N/A0.114%
8/7/2023 Acadian Asset Management LLC358,010$329K0.0%+15.1%0.036%
8/3/2023 Oppenheimer & Co. Inc.68,171$63K0.0%N/A0.007%
7/28/2023 Baillie Gifford & Co.17,176,135$15.89M0.0%+0.4%1.728%
7/11/2023 Harbor Capital Advisors Inc.112,516$104K0.0%N/A0.073%
5/17/2023 Long Focus Capital Management LLC5,435,439$5.93M0.3%+2.9%3.514%
5/12/2023 Long Focus Capital Management LLC2,772,791$3.02M0.3%-47.5%1.793%
Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)

I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.

Click here to see the details because I believe a lot of people will get rich.
5/10/2023 Simplify Asset Management Inc.150,000$164K0.0%N/A0.097%
5/3/2023 Baillie Gifford & Co.17,112,002$18.65M0.0%-0.3%11.064%
5/1/2023 Virtu Financial LLC88,234$96K0.0%+193.1%0.057%
4/25/2023Key Client Fiduciary Advisors LLC321,155$350K0.2%+8.2%0.208%
2/15/2023Endurant Capital Management LP1,733,236$2.53M1.0%-3.1%1.058%
2/14/2023 Susquehanna International Group LLP28,126$41K0.0%N/A0.017%
2/9/2023 HBK Sorce Advisory LLC70,000$65K0.0%+100.0%0.043%
1/17/2023Key Client Fiduciary Advisors LLC296,740$433K0.3%-31.9%0.181%
1/11/2023 Vigilare Wealth Management28,800$42K0.0%-21.7%0.018%
11/15/2022 PFM Health Sciences LP9,320,584$10.02M0.4%+2.3%5.689%
11/15/2022 Long Focus Capital Management LLC4,789,490$5.15M0.5%+2.4%2.923%
11/15/2022Endurant Capital Management LP1,788,517$1.92M0.6%-1.9%1.092%
11/14/2022 HBK Sorce Advisory LLC35,000$32K0.0%N/A0.021%
11/10/2022 ExodusPoint Capital Management LP370,288$398K0.0%+23.4%0.227%
11/7/2022 Virtu Financial LLC40,503$44K0.0%+133.7%0.025%
11/3/2022 Barclays PLC340,068$366K0.0%+34.6%0.208%
10/27/2022 Baillie Gifford & Co.14,664,936$15.76M0.0%-4.3%8.977%
10/12/2022Key Client Fiduciary Advisors LLC435,985$469K0.4%+4.8%0.267%
8/12/2022 Rafferty Asset Management LLC217,123$369K0.0%-59.5%0.134%
8/11/2022 Alps Advisors Inc.96,110$163K0.0%N/A0.059%
8/10/2022 Hunter Associates Investment Management LLC28,500$49K0.0%+42.5%0.018%
8/8/2022 Baillie Gifford & Co.15,321,346$26.05M0.0%-0.4%9.457%
7/11/2022 Vigilare Wealth Management41,800$71K0.1%N/A0.026%
5/17/2022Endurant Capital Management LP2,160,890$4.45M1.2%+140.7%1.335%
5/16/2022 Eversept Partners LP237,086$488K0.0%-32.0%0.151%
5/11/2022 GSA Capital Partners LLP69,612$143K0.0%-17.3%0.044%
5/5/2022 Baillie Gifford & Co.15,380,538$31.68M0.0%+11.8%9.805%
5/5/2022Levy Wealth Management Group LLC17,590$36K0.0%N/A0.011%
4/29/2022 Daiwa Securities Group Inc.35,516$73K0.0%+44.9%0.023%
4/26/2022 Hunter Associates Investment Management LLC20,000$41K0.0%+81.8%0.013%
4/21/2022 Inspire Investing LLC31,928$66K0.0%+107.4%0.020%
4/21/2022Inspire Advisors LLC45,105$93K0.0%+193.0%0.029%
4/18/2022Key Client Fiduciary Advisors LLC420,447$866K0.7%+58.0%0.268%
2/14/2022 Long Focus Capital Management LLC2,162,313$8.11M1.1%N/A1.384%
2/14/2022 Point72 Asset Management L.P.565,208$2.12M0.0%+640.8%0.362%
2/14/2022 DAFNA Capital Management LLC136,266$511K0.1%N/A0.087%
2/14/2022 Eversept Partners LP348,716$1.31M0.1%-21.6%0.223%
2/14/2022 GSA Capital Partners LLP84,129$315K0.0%-82.6%0.054%
2/11/2022 Syncona Portfolio Ltd1,377,294$5.17M4.9%N/A0.882%
2/10/2022 Rafferty Asset Management LLC606,763$2.28M0.0%-18.1%0.388%
2/8/2022 Bank of America Corp DE538,111$2.02M0.0%-26.5%0.344%
2/8/2022 ProShare Advisors LLC19,315$72K0.0%-34.0%0.012%
2/7/2022 Mitsubishi UFJ Kokusai Asset Management Co. Ltd.69,140$281K0.0%+13.6%0.044%
2/3/2022 Daiwa Securities Group Inc.24,515$92K0.0%+59.4%0.016%
2/3/2022 Inspire Investing LLC15,393$58K0.0%N/A0.010%
1/27/2022 Hunter Associates Investment Management LLC11,000$41K0.0%N/A0.007%
1/20/2022 Baillie Gifford & Co.13,756,352$51.59M0.0%+7.3%8.807%
12/1/2021 Balyasny Asset Management LLC259,413$1.34M0.0%N/A0.166%
11/18/2021 Personal CFO Solutions LLC36,388$188K0.0%+19.7%0.023%
11/16/2021 Schonfeld Strategic Advisors LLC349,683$1.81M0.0%-1.7%0.224%
This Indicator called BOTH NVDA rallies (Ad)

Rarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is…

11/16/2021ACT Capital L.L.C.90,000$465K0.2%N/A0.058%
11/16/2021 Squarepoint Ops LLC31,881$165K0.0%+127.8%0.020%
11/16/2021 Toroso Investments LLC10,554$55K0.0%N/A0.007%
11/16/2021 Millennium Management LLC1,584,849$8.19M0.0%+70.3%1.015%
11/15/2021 Point72 Asset Management L.P.76,300$394K0.0%-96.3%0.049%
11/15/2021 Cubist Systematic Strategies LLC57,953$300K0.0%+485.4%0.037%
11/15/2021 Man Group plc148,305$767K0.0%+44.2%0.095%
11/15/2021 Tudor Investment Corp Et Al16,004$83K0.0%N/A0.010%
11/15/2021 Rock Springs Capital Management LP2,189,788$11.32M0.2%+41.7%1.403%
11/15/2021 Marshall Wace LLP1,553,800$8.03M0.0%N/A0.995%
(Data available from 1/1/2016 forward)

ADAP Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ADAP shares?

During the previous two years, 34 institutional investors and hedge funds held shares of Adaptimmune Therapeutics. The most heavily invested institutionals were Matrix Capital Management Company LP ($35.81M), Baker BROS. Advisors LP ($17.04M), Baillie Gifford & Co. ($15.94M), Long Focus Capital Management LLC ($12.04M), PFM Health Sciences LP ($9.51M), MPM Asset Management LLC ($5.82M), and Endurant Capital Management LP ($2.53M).Learn more on ADAP's institutional investors.

What percentage of Adaptimmune Therapeutics stock is owned by institutional investors?

31.37% of Adaptimmune Therapeutics stock is owned by institutional investors. Learn more on ADAP's institutional investor holdings.

Which institutional investors have been buying Adaptimmune Therapeutics stock?

Of the 28 institutional investors that purchased Adaptimmune Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: MPM Asset Management LLC ($6.29M), Long Focus Capital Management LLC ($1.81M), Baillie Gifford & Co. ($1.69M), Artal Group S.A. ($1.13M), Acuitas Investments LLC ($479.76K), Renaissance Technologies LLC ($394.57K), and Simplify Asset Management Inc. ($150K).

How much institutional buying is happening at Adaptimmune Therapeutics?

Institutional investors have bought a total of 13,239,155 shares in the last 24 months. This purchase volume represents approximately $12.48M in transactions.

Which Adaptimmune Therapeutics major shareholders have been selling company stock?

Of the 10 institutional investors that sold Adaptimmune Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Long Focus Capital Management LLC ($2.51M), Baillie Gifford & Co. ($2.08M), Matrix Capital Management Company LP ($1.29M), PFM Health Sciences LP ($519.44K), Key Client Fiduciary Advisors LLC ($207.21K), Baker BROS. Advisors LP ($182.26K), and GSA Capital Partners LLP ($138.63K).

How much institutional selling is happening at Adaptimmune Therapeutics?

Institutional investors have sold a total of 7,108,344 shares in the last 24 months. This volume of shares sold represents approximately $7.31M in transactions.



This page (NASDAQ:ADAP) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners